Non-Small Cell Lung Cancer p53 Hotspot Mutation Cell Line Panel Item ID: ATCTCP2030
| Permits and Restrictions |
View Permits |
|---|---|
| Organism | Homo sapiens, human |
| Components | BEAS-2B, ATCC CRL-9609 A549, ATCC CCL-185 NCI-H1299, ATCC CRL-5803 NCI-H596, ATCC HTB-178 NCI-H1770, ATCC CRL-5893 NCI-H1975, ATCC CRL-5908 |
| Applications | Biological understanding of top genetic alterations across tumor types Novel anti-cancer drug targeting Reactivation of mutant p53 Studies related to p53 molecular mechanisms Testing small molecules or biologics for cancer drug development |
| Type Strain | no |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Comments | The Non-Small Cell Lung Cancer p53 Hotspot Mutation Cell Panel (ATCC TCP-2030) is comprised of 6 select cell lines derived from the lung that have been sequenced and validated by ATCC. The panel includes both WT p53 cell lines as well as cultures with p53 hotspot mutations at codons 245, 248, or 273. |
| Product Format | frozen |
| Storage Conditions | LN vapor (less than -130°C) only |
| Permits |
These permits may be required for shipping this product to Australia:
|
|---|---|
| Basic Documentation | Product Sheet Certificate of Analysis SDS |
| Other Documentation | p53 Hotspot Mutation Data |